Västmanlands sjukhus Västerås
Västerås, Sweden
NCT Number: NCT07104968
This observational study aims to evaluate risk factors of progress and adverse outcome of aortic regurgitation
Trial opening soon.
Get Notified18 year–100 year
All sexes
Observational
Västerås, Sweden
Aortic regurgitation is relatively common, with a prevalence of 13% for men and 8,5% for women in the Framingham study (Singh et al). Patients with aortic regurgitation are evaluated regularly with echocardiography to see if progress occurs, and suitable candidates are referred for surgical repair or replacement of the aortic valve.
However, an American study from 2019 showed that only 12% of cases of aortic regurgitation progressed from mild to moderate or severe over a 10 years period (Yang et al). This means that the majority of patients undergo echocardiographic evaluations without a clinical benefit.
It is unclear whether these findings also apply to a Swedish population with the European definitions for aortic regurgitation.
Aim:
To do a retrospective analysis of patients evaluated with echocardiography in Västerås, Sweden between January 2003 and March 2025 to describe the prevalence of aortic regurgitation as well as aortic dilatation, to describe how often progress occurs in patients with mild or moderate aortic regurgitation, and finally to look at factors (clinical, echocardiographic) associated with progress of aortic regurgitation as well as outcome (mortality, MACE, cardiac surgery).
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Depending on when the patients was evaluated first, up to approximately 20 years of follow-up
Progress of aortic regurgitation from mild to moderate or severe, or moderate to severe. Progress is defined according to current European Society for Cardiology guidelines using a comprehensive echocardiographic assessment
Time frame: Depending on when the patients was evaluated first, up to approximately 20 years of follow-up
Surgical treatment of aortic regurgitation or aortic aneurysm
Time frame: Depending on when the patients was evaluated first, up to approximately 20 years of follow-up
Hospitalization for heart failure during follow-up
Time frame: Depending on when the patients was evaluated first, up to approximately 20 years of follow-up
Composite endpoint
Time frame: Depending on when the patients was evaluated first, up to approximately 20 years of follow-up
All-cause mortality during follow-up
Contact information is provided by the study sponsor or research team.
Uppsala University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07605624
Aortic Regurgitation, Aortic Stenosis
Beijing, Beijing Municipality, China
View Trial DetailsNCT07458672
Aortic Regurgitation, Aortic Valve Disease
View Trial DetailsNCT07453849
Aortic Regurgitation, Aortic Valve Disease
Beijing, Beijing Municipality, China
View Trial DetailsNCT06594705
Aortic Insufficiency, Aortic Regurgitation
Los Angeles, California, United States
View Trial Details